ClinicalTrials.Veeva

Menu

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Almirall logo

Almirall

Status and phase

Completed
Phase 1

Conditions

Healthy Volunteers

Treatments

Drug: dapsone gel vehicle
Drug: dapsone gel

Study type

Interventional

Funder types

Industry

Identifiers

NCT02108483
225678-010

Details and patient eligibility

About

This study will evaluate the potential of dapsone gel and its vehicle to cause a phototoxic reaction following irradiation of the skin under controlled conditions.

Enrollment

33 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

-Healthy adults.

Exclusion criteria

  • Skin diseases, excessive hair, tattoos, pigmentation, scars or moles that could interfere with patch application
  • Sensitivity to adhesive bandages or tape.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Triple Blind

33 participants in 1 patient group

All participants
Experimental group
Description:
Dapsone gel and dapsone gel vehicle applied to the skin by separate occlusive patches on Day 1.
Treatment:
Drug: dapsone gel vehicle
Drug: dapsone gel

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems